Global Transfusion Diagnosis for Donor Market Growth (Status and Outlook) 2026-2032
The global Transfusion Diagnosis for Donor market size is predicted to grow from US$ 4402 million in 2025 to US$ 6479 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.
The gross profit margin of major companies in the industry is between 50% ? 70%.
Transfusion Diagnosis for Donors refers to the critical medical screening and testing process performed on blood donors to ensure the safety and compatibility of blood products. This includes mandatory screening for transfusion-transmitted infections (TTIs) such as HIV, Hepatitis B and C, and Syphilis using Nucleic Acid Testing (NAT) and ELISA. It also encompasses blood group serology (ABO/Rh typing) and cross-matching. These procedures are fundamental to modern hemovigilance, ensuring every blood unit meets stringent clinical safety standards to prevent adverse reactions in recipients.
The industrial chain begins upstream with providers of biological raw materials (antigens, antibodies, enzymes), precision optical sensors, microfluidic chips, and high-purity reagents. The midstream consists of manufacturers of automated blood screening platforms, molecular diagnostic systems, and immunoassays. Downstream applications include national and regional blood centers, hospital blood banks, and plasma collection stations. The chain is supported by cold-chain logistics providers and regulatory bodies. Service providers offer calibration, system maintenance, and integrated blood management software to track blood units from collection to clinical transfusion, ensuring full traceability and safety.
The market for transfusion diagnosis is witnessing a significant shift toward automated and molecular-based testing to minimize the 'window period' of infection detection. Increasing global healthcare expenditures and aging populations are driving the demand for safe blood supplies. A key trend is the integration of Nucleic Acid Testing (NAT) with traditional serology to enhance sensitivity. Furthermore, the adoption of Big Data and AI in blood management systems is optimizing inventory and reducing wastage. While stringent regulatory requirements pose a high entry barrier, the expansion of blood banking infrastructure in emerging economies provides substantial growth opportunities. Manufacturers are focusing on high-throughput systems that reduce manual errors while maintaining the highest levels of diagnostic accuracy and safety.
LPI (LP Information)' newest research report, the ?Transfusion Diagnosis for Donor Industry Forecast? looks at past sales and reviews total world Transfusion Diagnosis for Donor sales in 2025, providing a comprehensive analysis by region and market sector of projected Transfusion Diagnosis for Donor sales for 2026 through 2032. With Transfusion Diagnosis for Donor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transfusion Diagnosis for Donor industry.
This Insight Report provides a comprehensive analysis of the global Transfusion Diagnosis for Donor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transfusion Diagnosis for Donor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Transfusion Diagnosis for Donor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transfusion Diagnosis for Donor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transfusion Diagnosis for Donor.
This report presents a comprehensive overview, market shares, and growth opportunities of Transfusion Diagnosis for Donor market by product type, application, key players and key regions and countries.
Segmentation by Type:
The gross profit margin of major companies in the industry is between 50% ? 70%.
Transfusion Diagnosis for Donors refers to the critical medical screening and testing process performed on blood donors to ensure the safety and compatibility of blood products. This includes mandatory screening for transfusion-transmitted infections (TTIs) such as HIV, Hepatitis B and C, and Syphilis using Nucleic Acid Testing (NAT) and ELISA. It also encompasses blood group serology (ABO/Rh typing) and cross-matching. These procedures are fundamental to modern hemovigilance, ensuring every blood unit meets stringent clinical safety standards to prevent adverse reactions in recipients.
The industrial chain begins upstream with providers of biological raw materials (antigens, antibodies, enzymes), precision optical sensors, microfluidic chips, and high-purity reagents. The midstream consists of manufacturers of automated blood screening platforms, molecular diagnostic systems, and immunoassays. Downstream applications include national and regional blood centers, hospital blood banks, and plasma collection stations. The chain is supported by cold-chain logistics providers and regulatory bodies. Service providers offer calibration, system maintenance, and integrated blood management software to track blood units from collection to clinical transfusion, ensuring full traceability and safety.
The market for transfusion diagnosis is witnessing a significant shift toward automated and molecular-based testing to minimize the 'window period' of infection detection. Increasing global healthcare expenditures and aging populations are driving the demand for safe blood supplies. A key trend is the integration of Nucleic Acid Testing (NAT) with traditional serology to enhance sensitivity. Furthermore, the adoption of Big Data and AI in blood management systems is optimizing inventory and reducing wastage. While stringent regulatory requirements pose a high entry barrier, the expansion of blood banking infrastructure in emerging economies provides substantial growth opportunities. Manufacturers are focusing on high-throughput systems that reduce manual errors while maintaining the highest levels of diagnostic accuracy and safety.
LPI (LP Information)' newest research report, the ?Transfusion Diagnosis for Donor Industry Forecast? looks at past sales and reviews total world Transfusion Diagnosis for Donor sales in 2025, providing a comprehensive analysis by region and market sector of projected Transfusion Diagnosis for Donor sales for 2026 through 2032. With Transfusion Diagnosis for Donor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transfusion Diagnosis for Donor industry.
This Insight Report provides a comprehensive analysis of the global Transfusion Diagnosis for Donor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transfusion Diagnosis for Donor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Transfusion Diagnosis for Donor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transfusion Diagnosis for Donor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transfusion Diagnosis for Donor.
This report presents a comprehensive overview, market shares, and growth opportunities of Transfusion Diagnosis for Donor market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Instruments
- Kits and Reagents
- Blood Grouping & Typing Diagnostics
- Infectious Disease Screening Diagnostics
- Immunoassay-Based Diagnostics
- Molecular Diagnostics
- Blood Banks
- Blood Donation/Transfusion Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Grifols
- F. Hoffmann-La Roche
- Abbott
- Bio-Rad Laboratories
- Werfen
- QuidelOrtho Corporation
- AliveDx Holdings Finance
- BAG Diagnostics GmbH
- Diasorin
- Prestige Diagnostics
- Atlas Medical GmbH
- Lorne Laboratories
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transfusion Diagnosis for Donor Market Size (2021-2032)
2.1.2 Transfusion Diagnosis for Donor Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Transfusion Diagnosis for Donor by Country/Region (2021, 2025 & 2032)
2.2 Transfusion Diagnosis for Donor Segment by Type
2.2.1 Instruments
2.2.2 Kits and Reagents
2.2.3 Transfusion Diagnosis for Donor Market Size by Type
2.2.3.1 Transfusion Diagnosis for Donor Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
2.3 Transfusion Diagnosis for Donor Segment by Diagnostic Purpose
2.3.1 Blood Grouping & Typing Diagnostics
2.3.2 Infectious Disease Screening Diagnostics
2.3.3 Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose
2.3.3.1 Transfusion Diagnosis for Donor Market Size CAGR by Diagnostic Purpose (2021 VS 2025 VS 2032)
2.3.3.2 Global Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose (2021-2026)
2.4 Transfusion Diagnosis for Donor Segment by Testing Method
2.4.1 Immunoassay-Based Diagnostics
2.4.2 Molecular Diagnostics
2.4.3 Transfusion Diagnosis for Donor Market Size by Testing Method
2.4.3.1 Transfusion Diagnosis for Donor Market Size CAGR by Testing Method (2021 VS 2025 VS 2032)
2.4.3.2 Global Transfusion Diagnosis for Donor Market Size Market Share by Testing Method (2021-2026)
2.5 Transfusion Diagnosis for Donor Segment by Application
2.5.1 Blood Banks
2.5.2 Blood Donation/Transfusion Centers
2.5.3 Others
2.5.4 Transfusion Diagnosis for Donor Market Size by Application
2.5.4.1 Transfusion Diagnosis for Donor Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
3 TRANSFUSION DIAGNOSIS FOR DONOR MARKET SIZE BY PLAYER
3.1 Transfusion Diagnosis for Donor Market Size Market Share by Player
3.1.1 Global Transfusion Diagnosis for Donor Revenue by Player (2021-2026)
3.1.2 Global Transfusion Diagnosis for Donor Revenue Market Share by Player (2021-2026)
3.2 Global Transfusion Diagnosis for Donor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TRANSFUSION DIAGNOSIS FOR DONOR BY REGION
4.1 Transfusion Diagnosis for Donor Market Size by Region (2021-2026)
4.2 Global Transfusion Diagnosis for Donor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Transfusion Diagnosis for Donor Market Size Growth (2021-2026)
4.4 APAC Transfusion Diagnosis for Donor Market Size Growth (2021-2026)
4.5 Europe Transfusion Diagnosis for Donor Market Size Growth (2021-2026)
4.6 Middle East & Africa Transfusion Diagnosis for Donor Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
5.2 Americas Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
5.3 Americas Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transfusion Diagnosis for Donor Market Size by Region (2021-2026)
6.2 APAC Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
6.3 APAC Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
7.2 Europe Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
7.3 Europe Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transfusion Diagnosis for Donor by Region (2021-2026)
8.2 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
8.3 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TRANSFUSION DIAGNOSIS FOR DONOR MARKET FORECAST
10.1 Global Transfusion Diagnosis for Donor Forecast by Region (2027-2032)
10.1.1 Global Transfusion Diagnosis for Donor Forecast by Region (2027-2032)
10.1.2 Americas Transfusion Diagnosis for Donor Forecast
10.1.3 APAC Transfusion Diagnosis for Donor Forecast
10.1.4 Europe Transfusion Diagnosis for Donor Forecast
10.1.5 Middle East & Africa Transfusion Diagnosis for Donor Forecast
10.2 Americas Transfusion Diagnosis for Donor Forecast by Country (2027-2032)
10.2.1 United States Market Transfusion Diagnosis for Donor Forecast
10.2.2 Canada Market Transfusion Diagnosis for Donor Forecast
10.2.3 Mexico Market Transfusion Diagnosis for Donor Forecast
10.2.4 Brazil Market Transfusion Diagnosis for Donor Forecast
10.3 APAC Transfusion Diagnosis for Donor Forecast by Region (2027-2032)
10.3.1 China Transfusion Diagnosis for Donor Market Forecast
10.3.2 Japan Market Transfusion Diagnosis for Donor Forecast
10.3.3 Korea Market Transfusion Diagnosis for Donor Forecast
10.3.4 Southeast Asia Market Transfusion Diagnosis for Donor Forecast
10.3.5 India Market Transfusion Diagnosis for Donor Forecast
10.3.6 Australia Market Transfusion Diagnosis for Donor Forecast
10.4 Europe Transfusion Diagnosis for Donor Forecast by Country (2027-2032)
10.4.1 Germany Market Transfusion Diagnosis for Donor Forecast
10.4.2 France Market Transfusion Diagnosis for Donor Forecast
10.4.3 UK Market Transfusion Diagnosis for Donor Forecast
10.4.4 Italy Market Transfusion Diagnosis for Donor Forecast
10.4.5 Russia Market Transfusion Diagnosis for Donor Forecast
10.5 Middle East & Africa Transfusion Diagnosis for Donor Forecast by Region (2027-2032)
10.5.1 Egypt Market Transfusion Diagnosis for Donor Forecast
10.5.2 South Africa Market Transfusion Diagnosis for Donor Forecast
10.5.3 Israel Market Transfusion Diagnosis for Donor Forecast
10.5.4 Turkey Market Transfusion Diagnosis for Donor Forecast
10.6 Global Transfusion Diagnosis for Donor Forecast by Type (2027-2032)
10.7 Global Transfusion Diagnosis for Donor Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Transfusion Diagnosis for Donor Forecast
11 KEY PLAYERS ANALYSIS
11.1 Grifols
11.1.1 Grifols Company Information
11.1.2 Grifols Transfusion Diagnosis for Donor Product Offered
11.1.3 Grifols Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Grifols Main Business Overview
11.1.5 Grifols Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Offered
11.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Transfusion Diagnosis for Donor Product Offered
11.3.3 Abbott Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Information
11.4.2 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Offered
11.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bio-Rad Laboratories Main Business Overview
11.4.5 Bio-Rad Laboratories Latest Developments
11.5 Werfen
11.5.1 Werfen Company Information
11.5.2 Werfen Transfusion Diagnosis for Donor Product Offered
11.5.3 Werfen Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Werfen Main Business Overview
11.5.5 Werfen Latest Developments
11.6 QuidelOrtho Corporation
11.6.1 QuidelOrtho Corporation Company Information
11.6.2 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Offered
11.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 QuidelOrtho Corporation Main Business Overview
11.6.5 QuidelOrtho Corporation Latest Developments
11.7 AliveDx Holdings Finance
11.7.1 AliveDx Holdings Finance Company Information
11.7.2 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Offered
11.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AliveDx Holdings Finance Main Business Overview
11.7.5 AliveDx Holdings Finance Latest Developments
11.8 BAG Diagnostics GmbH
11.8.1 BAG Diagnostics GmbH Company Information
11.8.2 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Offered
11.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BAG Diagnostics GmbH Main Business Overview
11.8.5 BAG Diagnostics GmbH Latest Developments
11.9 Diasorin
11.9.1 Diasorin Company Information
11.9.2 Diasorin Transfusion Diagnosis for Donor Product Offered
11.9.3 Diasorin Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Diasorin Main Business Overview
11.9.5 Diasorin Latest Developments
11.10 Prestige Diagnostics
11.10.1 Prestige Diagnostics Company Information
11.10.2 Prestige Diagnostics Transfusion Diagnosis for Donor Product Offered
11.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Prestige Diagnostics Main Business Overview
11.10.5 Prestige Diagnostics Latest Developments
11.11 Atlas Medical GmbH
11.11.1 Atlas Medical GmbH Company Information
11.11.2 Atlas Medical GmbH Transfusion Diagnosis for Donor Product Offered
11.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Atlas Medical GmbH Main Business Overview
11.11.5 Atlas Medical GmbH Latest Developments
11.12 Lorne Laboratories
11.12.1 Lorne Laboratories Company Information
11.12.2 Lorne Laboratories Transfusion Diagnosis for Donor Product Offered
11.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Lorne Laboratories Main Business Overview
11.12.5 Lorne Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transfusion Diagnosis for Donor Market Size (2021-2032)
2.1.2 Transfusion Diagnosis for Donor Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Transfusion Diagnosis for Donor by Country/Region (2021, 2025 & 2032)
2.2 Transfusion Diagnosis for Donor Segment by Type
2.2.1 Instruments
2.2.2 Kits and Reagents
2.2.3 Transfusion Diagnosis for Donor Market Size by Type
2.2.3.1 Transfusion Diagnosis for Donor Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
2.3 Transfusion Diagnosis for Donor Segment by Diagnostic Purpose
2.3.1 Blood Grouping & Typing Diagnostics
2.3.2 Infectious Disease Screening Diagnostics
2.3.3 Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose
2.3.3.1 Transfusion Diagnosis for Donor Market Size CAGR by Diagnostic Purpose (2021 VS 2025 VS 2032)
2.3.3.2 Global Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose (2021-2026)
2.4 Transfusion Diagnosis for Donor Segment by Testing Method
2.4.1 Immunoassay-Based Diagnostics
2.4.2 Molecular Diagnostics
2.4.3 Transfusion Diagnosis for Donor Market Size by Testing Method
2.4.3.1 Transfusion Diagnosis for Donor Market Size CAGR by Testing Method (2021 VS 2025 VS 2032)
2.4.3.2 Global Transfusion Diagnosis for Donor Market Size Market Share by Testing Method (2021-2026)
2.5 Transfusion Diagnosis for Donor Segment by Application
2.5.1 Blood Banks
2.5.2 Blood Donation/Transfusion Centers
2.5.3 Others
2.5.4 Transfusion Diagnosis for Donor Market Size by Application
2.5.4.1 Transfusion Diagnosis for Donor Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
3 TRANSFUSION DIAGNOSIS FOR DONOR MARKET SIZE BY PLAYER
3.1 Transfusion Diagnosis for Donor Market Size Market Share by Player
3.1.1 Global Transfusion Diagnosis for Donor Revenue by Player (2021-2026)
3.1.2 Global Transfusion Diagnosis for Donor Revenue Market Share by Player (2021-2026)
3.2 Global Transfusion Diagnosis for Donor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TRANSFUSION DIAGNOSIS FOR DONOR BY REGION
4.1 Transfusion Diagnosis for Donor Market Size by Region (2021-2026)
4.2 Global Transfusion Diagnosis for Donor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Transfusion Diagnosis for Donor Market Size Growth (2021-2026)
4.4 APAC Transfusion Diagnosis for Donor Market Size Growth (2021-2026)
4.5 Europe Transfusion Diagnosis for Donor Market Size Growth (2021-2026)
4.6 Middle East & Africa Transfusion Diagnosis for Donor Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
5.2 Americas Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
5.3 Americas Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transfusion Diagnosis for Donor Market Size by Region (2021-2026)
6.2 APAC Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
6.3 APAC Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
7.2 Europe Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
7.3 Europe Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transfusion Diagnosis for Donor by Region (2021-2026)
8.2 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
8.3 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TRANSFUSION DIAGNOSIS FOR DONOR MARKET FORECAST
10.1 Global Transfusion Diagnosis for Donor Forecast by Region (2027-2032)
10.1.1 Global Transfusion Diagnosis for Donor Forecast by Region (2027-2032)
10.1.2 Americas Transfusion Diagnosis for Donor Forecast
10.1.3 APAC Transfusion Diagnosis for Donor Forecast
10.1.4 Europe Transfusion Diagnosis for Donor Forecast
10.1.5 Middle East & Africa Transfusion Diagnosis for Donor Forecast
10.2 Americas Transfusion Diagnosis for Donor Forecast by Country (2027-2032)
10.2.1 United States Market Transfusion Diagnosis for Donor Forecast
10.2.2 Canada Market Transfusion Diagnosis for Donor Forecast
10.2.3 Mexico Market Transfusion Diagnosis for Donor Forecast
10.2.4 Brazil Market Transfusion Diagnosis for Donor Forecast
10.3 APAC Transfusion Diagnosis for Donor Forecast by Region (2027-2032)
10.3.1 China Transfusion Diagnosis for Donor Market Forecast
10.3.2 Japan Market Transfusion Diagnosis for Donor Forecast
10.3.3 Korea Market Transfusion Diagnosis for Donor Forecast
10.3.4 Southeast Asia Market Transfusion Diagnosis for Donor Forecast
10.3.5 India Market Transfusion Diagnosis for Donor Forecast
10.3.6 Australia Market Transfusion Diagnosis for Donor Forecast
10.4 Europe Transfusion Diagnosis for Donor Forecast by Country (2027-2032)
10.4.1 Germany Market Transfusion Diagnosis for Donor Forecast
10.4.2 France Market Transfusion Diagnosis for Donor Forecast
10.4.3 UK Market Transfusion Diagnosis for Donor Forecast
10.4.4 Italy Market Transfusion Diagnosis for Donor Forecast
10.4.5 Russia Market Transfusion Diagnosis for Donor Forecast
10.5 Middle East & Africa Transfusion Diagnosis for Donor Forecast by Region (2027-2032)
10.5.1 Egypt Market Transfusion Diagnosis for Donor Forecast
10.5.2 South Africa Market Transfusion Diagnosis for Donor Forecast
10.5.3 Israel Market Transfusion Diagnosis for Donor Forecast
10.5.4 Turkey Market Transfusion Diagnosis for Donor Forecast
10.6 Global Transfusion Diagnosis for Donor Forecast by Type (2027-2032)
10.7 Global Transfusion Diagnosis for Donor Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Transfusion Diagnosis for Donor Forecast
11 KEY PLAYERS ANALYSIS
11.1 Grifols
11.1.1 Grifols Company Information
11.1.2 Grifols Transfusion Diagnosis for Donor Product Offered
11.1.3 Grifols Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Grifols Main Business Overview
11.1.5 Grifols Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Offered
11.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Transfusion Diagnosis for Donor Product Offered
11.3.3 Abbott Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Information
11.4.2 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Offered
11.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bio-Rad Laboratories Main Business Overview
11.4.5 Bio-Rad Laboratories Latest Developments
11.5 Werfen
11.5.1 Werfen Company Information
11.5.2 Werfen Transfusion Diagnosis for Donor Product Offered
11.5.3 Werfen Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Werfen Main Business Overview
11.5.5 Werfen Latest Developments
11.6 QuidelOrtho Corporation
11.6.1 QuidelOrtho Corporation Company Information
11.6.2 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Offered
11.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 QuidelOrtho Corporation Main Business Overview
11.6.5 QuidelOrtho Corporation Latest Developments
11.7 AliveDx Holdings Finance
11.7.1 AliveDx Holdings Finance Company Information
11.7.2 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Offered
11.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AliveDx Holdings Finance Main Business Overview
11.7.5 AliveDx Holdings Finance Latest Developments
11.8 BAG Diagnostics GmbH
11.8.1 BAG Diagnostics GmbH Company Information
11.8.2 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Offered
11.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BAG Diagnostics GmbH Main Business Overview
11.8.5 BAG Diagnostics GmbH Latest Developments
11.9 Diasorin
11.9.1 Diasorin Company Information
11.9.2 Diasorin Transfusion Diagnosis for Donor Product Offered
11.9.3 Diasorin Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Diasorin Main Business Overview
11.9.5 Diasorin Latest Developments
11.10 Prestige Diagnostics
11.10.1 Prestige Diagnostics Company Information
11.10.2 Prestige Diagnostics Transfusion Diagnosis for Donor Product Offered
11.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Prestige Diagnostics Main Business Overview
11.10.5 Prestige Diagnostics Latest Developments
11.11 Atlas Medical GmbH
11.11.1 Atlas Medical GmbH Company Information
11.11.2 Atlas Medical GmbH Transfusion Diagnosis for Donor Product Offered
11.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Atlas Medical GmbH Main Business Overview
11.11.5 Atlas Medical GmbH Latest Developments
11.12 Lorne Laboratories
11.12.1 Lorne Laboratories Company Information
11.12.2 Lorne Laboratories Transfusion Diagnosis for Donor Product Offered
11.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Lorne Laboratories Main Business Overview
11.12.5 Lorne Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Transfusion Diagnosis for Donor Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Transfusion Diagnosis for Donor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Instruments
Table 4. Major Players of Kits and Reagents
Table 5. Transfusion Diagnosis for Donor Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Blood Grouping & Typing Diagnostics
Table 9. Major Players of Infectious Disease Screening Diagnostics
Table 10. Transfusion Diagnosis for Donor Market Size CAGR by Diagnostic Purpose (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose (2021-2026) & ($ millions)
Table 12. Global Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose (2021-2026)
Table 13. Major Players of Immunoassay-Based Diagnostics
Table 14. Major Players of Molecular Diagnostics
Table 15. Transfusion Diagnosis for Donor Market Size CAGR by Testing Method (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Transfusion Diagnosis for Donor Market Size by Testing Method (2021-2026) & ($ millions)
Table 17. Global Transfusion Diagnosis for Donor Market Size Market Share by Testing Method (2021-2026)
Table 18. Transfusion Diagnosis for Donor Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Table 21. Global Transfusion Diagnosis for Donor Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Transfusion Diagnosis for Donor Revenue Market Share by Player (2021-2026)
Table 23. Transfusion Diagnosis for Donor Key Players Head office and Products Offered
Table 24. Transfusion Diagnosis for Donor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Transfusion Diagnosis for Donor Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Transfusion Diagnosis for Donor Market Size Market Share by Region (2021-2026)
Table 29. Global Transfusion Diagnosis for Donor Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Transfusion Diagnosis for Donor Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Transfusion Diagnosis for Donor Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Transfusion Diagnosis for Donor Market Size Market Share by Country (2021-2026)
Table 33. Americas Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Table 35. Americas Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Table 37. APAC Transfusion Diagnosis for Donor Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Transfusion Diagnosis for Donor Market Size Market Share by Region (2021-2026)
Table 39. APAC Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Transfusion Diagnosis for Donor Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Transfusion Diagnosis for Donor Market Size Market Share by Country (2021-2026)
Table 43. Europe Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Transfusion Diagnosis for Donor
Table 49. Key Market Challenges & Risks of Transfusion Diagnosis for Donor
Table 50. Key Industry Trends of Transfusion Diagnosis for Donor
Table 51. Global Transfusion Diagnosis for Donor Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Transfusion Diagnosis for Donor Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Transfusion Diagnosis for Donor Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Transfusion Diagnosis for Donor Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Grifols Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 56. Grifols Transfusion Diagnosis for Donor Product Offered
Table 57. Grifols Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Grifols Main Business
Table 59. Grifols Latest Developments
Table 60. F. Hoffmann-La Roche Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 61. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Offered
Table 62. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. F. Hoffmann-La Roche Main Business
Table 64. F. Hoffmann-La Roche Latest Developments
Table 65. Abbott Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 66. Abbott Transfusion Diagnosis for Donor Product Offered
Table 67. Abbott Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Abbott Main Business
Table 69. Abbott Latest Developments
Table 70. Bio-Rad Laboratories Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 71. Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Offered
Table 72. Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Bio-Rad Laboratories Main Business
Table 74. Bio-Rad Laboratories Latest Developments
Table 75. Werfen Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 76. Werfen Transfusion Diagnosis for Donor Product Offered
Table 77. Werfen Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Werfen Main Business
Table 79. Werfen Latest Developments
Table 80. QuidelOrtho Corporation Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 81. QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Offered
Table 82. QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. QuidelOrtho Corporation Main Business
Table 84. QuidelOrtho Corporation Latest Developments
Table 85. AliveDx Holdings Finance Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 86. AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Offered
Table 87. AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. AliveDx Holdings Finance Main Business
Table 89. AliveDx Holdings Finance Latest Developments
Table 90. BAG Diagnostics GmbH Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 91. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Offered
Table 92. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. BAG Diagnostics GmbH Main Business
Table 94. BAG Diagnostics GmbH Latest Developments
Table 95. Diasorin Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 96. Diasorin Transfusion Diagnosis for Donor Product Offered
Table 97. Diasorin Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Diasorin Main Business
Table 99. Diasorin Latest Developments
Table 100. Prestige Diagnostics Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 101. Prestige Diagnostics Transfusion Diagnosis for Donor Product Offered
Table 102. Prestige Diagnostics Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Prestige Diagnostics Main Business
Table 104. Prestige Diagnostics Latest Developments
Table 105. Atlas Medical GmbH Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 106. Atlas Medical GmbH Transfusion Diagnosis for Donor Product Offered
Table 107. Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Atlas Medical GmbH Main Business
Table 109. Atlas Medical GmbH Latest Developments
Table 110. Lorne Laboratories Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 111. Lorne Laboratories Transfusion Diagnosis for Donor Product Offered
Table 112. Lorne Laboratories Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Lorne Laboratories Main Business
Table 114. Lorne Laboratories Latest Developments
Table 1. Transfusion Diagnosis for Donor Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Transfusion Diagnosis for Donor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Instruments
Table 4. Major Players of Kits and Reagents
Table 5. Transfusion Diagnosis for Donor Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Blood Grouping & Typing Diagnostics
Table 9. Major Players of Infectious Disease Screening Diagnostics
Table 10. Transfusion Diagnosis for Donor Market Size CAGR by Diagnostic Purpose (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose (2021-2026) & ($ millions)
Table 12. Global Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose (2021-2026)
Table 13. Major Players of Immunoassay-Based Diagnostics
Table 14. Major Players of Molecular Diagnostics
Table 15. Transfusion Diagnosis for Donor Market Size CAGR by Testing Method (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Transfusion Diagnosis for Donor Market Size by Testing Method (2021-2026) & ($ millions)
Table 17. Global Transfusion Diagnosis for Donor Market Size Market Share by Testing Method (2021-2026)
Table 18. Transfusion Diagnosis for Donor Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Table 21. Global Transfusion Diagnosis for Donor Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Transfusion Diagnosis for Donor Revenue Market Share by Player (2021-2026)
Table 23. Transfusion Diagnosis for Donor Key Players Head office and Products Offered
Table 24. Transfusion Diagnosis for Donor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Transfusion Diagnosis for Donor Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Transfusion Diagnosis for Donor Market Size Market Share by Region (2021-2026)
Table 29. Global Transfusion Diagnosis for Donor Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Transfusion Diagnosis for Donor Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Transfusion Diagnosis for Donor Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Transfusion Diagnosis for Donor Market Size Market Share by Country (2021-2026)
Table 33. Americas Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Table 35. Americas Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Table 37. APAC Transfusion Diagnosis for Donor Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Transfusion Diagnosis for Donor Market Size Market Share by Region (2021-2026)
Table 39. APAC Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Transfusion Diagnosis for Donor Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Transfusion Diagnosis for Donor Market Size Market Share by Country (2021-2026)
Table 43. Europe Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Transfusion Diagnosis for Donor
Table 49. Key Market Challenges & Risks of Transfusion Diagnosis for Donor
Table 50. Key Industry Trends of Transfusion Diagnosis for Donor
Table 51. Global Transfusion Diagnosis for Donor Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Transfusion Diagnosis for Donor Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Transfusion Diagnosis for Donor Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Transfusion Diagnosis for Donor Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Grifols Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 56. Grifols Transfusion Diagnosis for Donor Product Offered
Table 57. Grifols Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Grifols Main Business
Table 59. Grifols Latest Developments
Table 60. F. Hoffmann-La Roche Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 61. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Offered
Table 62. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. F. Hoffmann-La Roche Main Business
Table 64. F. Hoffmann-La Roche Latest Developments
Table 65. Abbott Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 66. Abbott Transfusion Diagnosis for Donor Product Offered
Table 67. Abbott Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Abbott Main Business
Table 69. Abbott Latest Developments
Table 70. Bio-Rad Laboratories Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 71. Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Offered
Table 72. Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Bio-Rad Laboratories Main Business
Table 74. Bio-Rad Laboratories Latest Developments
Table 75. Werfen Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 76. Werfen Transfusion Diagnosis for Donor Product Offered
Table 77. Werfen Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Werfen Main Business
Table 79. Werfen Latest Developments
Table 80. QuidelOrtho Corporation Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 81. QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Offered
Table 82. QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. QuidelOrtho Corporation Main Business
Table 84. QuidelOrtho Corporation Latest Developments
Table 85. AliveDx Holdings Finance Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 86. AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Offered
Table 87. AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. AliveDx Holdings Finance Main Business
Table 89. AliveDx Holdings Finance Latest Developments
Table 90. BAG Diagnostics GmbH Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 91. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Offered
Table 92. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. BAG Diagnostics GmbH Main Business
Table 94. BAG Diagnostics GmbH Latest Developments
Table 95. Diasorin Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 96. Diasorin Transfusion Diagnosis for Donor Product Offered
Table 97. Diasorin Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Diasorin Main Business
Table 99. Diasorin Latest Developments
Table 100. Prestige Diagnostics Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 101. Prestige Diagnostics Transfusion Diagnosis for Donor Product Offered
Table 102. Prestige Diagnostics Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Prestige Diagnostics Main Business
Table 104. Prestige Diagnostics Latest Developments
Table 105. Atlas Medical GmbH Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 106. Atlas Medical GmbH Transfusion Diagnosis for Donor Product Offered
Table 107. Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Atlas Medical GmbH Main Business
Table 109. Atlas Medical GmbH Latest Developments
Table 110. Lorne Laboratories Details, Company Type, Transfusion Diagnosis for Donor Area Served and Its Competitors
Table 111. Lorne Laboratories Transfusion Diagnosis for Donor Product Offered
Table 112. Lorne Laboratories Transfusion Diagnosis for Donor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Lorne Laboratories Main Business
Table 114. Lorne Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Transfusion Diagnosis for Donor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Transfusion Diagnosis for Donor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Transfusion Diagnosis for Donor Sales Market Share by Country/Region (2025)
Figure 8. Transfusion Diagnosis for Donor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Transfusion Diagnosis for Donor Market Size Market Share by Type in 2025
Figure 10. Global Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose in 2025
Figure 11. Global Transfusion Diagnosis for Donor Market Size Market Share by Testing Method in 2025
Figure 12. Transfusion Diagnosis for Donor in Blood Banks
Figure 13. Global Transfusion Diagnosis for Donor Market: Blood Banks (2021-2026) & ($ millions)
Figure 14. Transfusion Diagnosis for Donor in Blood Donation/Transfusion Centers
Figure 15. Global Transfusion Diagnosis for Donor Market: Blood Donation/Transfusion Centers (2021-2026) & ($ millions)
Figure 16. Transfusion Diagnosis for Donor in Others
Figure 17. Global Transfusion Diagnosis for Donor Market: Others (2021-2026) & ($ millions)
Figure 18. Global Transfusion Diagnosis for Donor Market Size Market Share by Application in 2025
Figure 19. Global Transfusion Diagnosis for Donor Revenue Market Share by Player in 2025
Figure 20. Global Transfusion Diagnosis for Donor Market Size Market Share by Region (2021-2026)
Figure 21. Americas Transfusion Diagnosis for Donor Market Size 2021-2026 ($ millions)
Figure 22. APAC Transfusion Diagnosis for Donor Market Size 2021-2026 ($ millions)
Figure 23. Europe Transfusion Diagnosis for Donor Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Transfusion Diagnosis for Donor Market Size 2021-2026 ($ millions)
Figure 25. Americas Transfusion Diagnosis for Donor Value Market Share by Country in 2025
Figure 26. United States Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Transfusion Diagnosis for Donor Market Size Market Share by Region in 2025
Figure 31. APAC Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Figure 32. APAC Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Figure 33. China Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 37. India Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Transfusion Diagnosis for Donor Market Size Market Share by Country in 2025
Figure 40. Europe Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Figure 41. Europe Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Figure 42. Germany Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 43. France Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Transfusion Diagnosis for Donor Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 56. APAC Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 57. Europe Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 59. United States Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 60. Canada Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 61. Mexico Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 62. Brazil Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 63. China Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 64. Japan Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 65. Korea Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 67. India Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 68. Australia Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 69. Germany Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 70. France Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 71. UK Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 72. Italy Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 73. Russia Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 74. Egypt Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 75. South Africa Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 76. Israel Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 77. Turkey Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 78. Global Transfusion Diagnosis for Donor Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Transfusion Diagnosis for Donor Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 1. Transfusion Diagnosis for Donor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Transfusion Diagnosis for Donor Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Transfusion Diagnosis for Donor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Transfusion Diagnosis for Donor Sales Market Share by Country/Region (2025)
Figure 8. Transfusion Diagnosis for Donor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Transfusion Diagnosis for Donor Market Size Market Share by Type in 2025
Figure 10. Global Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose in 2025
Figure 11. Global Transfusion Diagnosis for Donor Market Size Market Share by Testing Method in 2025
Figure 12. Transfusion Diagnosis for Donor in Blood Banks
Figure 13. Global Transfusion Diagnosis for Donor Market: Blood Banks (2021-2026) & ($ millions)
Figure 14. Transfusion Diagnosis for Donor in Blood Donation/Transfusion Centers
Figure 15. Global Transfusion Diagnosis for Donor Market: Blood Donation/Transfusion Centers (2021-2026) & ($ millions)
Figure 16. Transfusion Diagnosis for Donor in Others
Figure 17. Global Transfusion Diagnosis for Donor Market: Others (2021-2026) & ($ millions)
Figure 18. Global Transfusion Diagnosis for Donor Market Size Market Share by Application in 2025
Figure 19. Global Transfusion Diagnosis for Donor Revenue Market Share by Player in 2025
Figure 20. Global Transfusion Diagnosis for Donor Market Size Market Share by Region (2021-2026)
Figure 21. Americas Transfusion Diagnosis for Donor Market Size 2021-2026 ($ millions)
Figure 22. APAC Transfusion Diagnosis for Donor Market Size 2021-2026 ($ millions)
Figure 23. Europe Transfusion Diagnosis for Donor Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Transfusion Diagnosis for Donor Market Size 2021-2026 ($ millions)
Figure 25. Americas Transfusion Diagnosis for Donor Value Market Share by Country in 2025
Figure 26. United States Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Transfusion Diagnosis for Donor Market Size Market Share by Region in 2025
Figure 31. APAC Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Figure 32. APAC Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Figure 33. China Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 37. India Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Transfusion Diagnosis for Donor Market Size Market Share by Country in 2025
Figure 40. Europe Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Figure 41. Europe Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Figure 42. Germany Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 43. France Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Transfusion Diagnosis for Donor Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Transfusion Diagnosis for Donor Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 56. APAC Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 57. Europe Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 59. United States Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 60. Canada Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 61. Mexico Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 62. Brazil Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 63. China Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 64. Japan Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 65. Korea Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 67. India Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 68. Australia Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 69. Germany Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 70. France Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 71. UK Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 72. Italy Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 73. Russia Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 74. Egypt Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 75. South Africa Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 76. Israel Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 77. Turkey Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
Figure 78. Global Transfusion Diagnosis for Donor Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Transfusion Diagnosis for Donor Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Transfusion Diagnosis for Donor Market Size 2027-2032 ($ millions)
